Clinical Research Directory
Browse clinical research sites, groups, and studies.
Monitoring Patients With Repetitive Head Impact With Gamma-glutamylcysteine Supplementation
Sponsor: Pravat Mandal
Summary
The goal of this clinical trial is to test whether the gamma - glutamylcystiene (GGC) oral supplement can reach the brain and subsequently increase antioxidant glutathione (GSH) level in people with repetitive head impact (RHI). This will reduce the oxidative stress related injury in people with RHI.This unique study's main objective is to test the: 1. Change in GSH in brain and blood levels through GGC supplementation. 2. Change in the cognitive function in RHI patients due to GGC supplementation.
Official title: Patients With Repetitive Head Impact Orally Supplemented With Gamma-glutamylcysteine: An Open Label Trial With MR Spectroscopy and Neuropsychological Testing
Key Details
Gender
All
Age Range
30 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2026-04
Completion Date
2027-12-27
Last Updated
2026-04-09
Healthy Volunteers
No
Conditions
Interventions
Gamma-glutamylcysteine (GGC)
400mg tablet orally (two times) per day.
Locations (1)
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania, United States